Intraocular lens package
Latest Allergan Sales, Inc. Patents:
- GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
- Leucine-based motifs and enhanced biological persistence of clostridial neurotoxins
- Calcium blockers to treat proliferative vitreoretinopathy
- GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
- Pain treatment by peripheral administration of a neurotoxin
Description
FIG. 1 is a perspective view of the top, front and left sides of an intraocular lens package showing our new design;
FIG. 2 is a front elevational view thereof;
FIG. 3 is a top plan view thereof;
FIG. 4 is a left side elevational view thereof;
FIG. 5 is a right side elevational view thereof;
FIG. 6 is a rear elevational view thereof; and,
FIG. 7 is a bottom plan view thereof.
Referenced Cited
Patent History
Patent number: D431721
Type: Grant
Filed: Apr 15, 1999
Date of Patent: Oct 10, 2000
Assignee: Allergan Sales, Inc. (Irvine, CA)
Inventors: Daniel G. Brady (San Juan Capistrano, CA), Arlene Gwon (Newport Beach, CA), Jonas H. Bourghardt (Ventura, CA), Hector R. Santos (Camarillo, CA), Michael Collinson (Goleta, CA), Claude A. Vidal (Santa Barbara, CA)
Primary Examiner: Celia Murphy
Attorney: Stout, Uxa, Buyan & Mullins
Application Number: 0/103,457
Type: Grant
Filed: Apr 15, 1999
Date of Patent: Oct 10, 2000
Assignee: Allergan Sales, Inc. (Irvine, CA)
Inventors: Daniel G. Brady (San Juan Capistrano, CA), Arlene Gwon (Newport Beach, CA), Jonas H. Bourghardt (Ventura, CA), Hector R. Santos (Camarillo, CA), Michael Collinson (Goleta, CA), Claude A. Vidal (Santa Barbara, CA)
Primary Examiner: Celia Murphy
Attorney: Stout, Uxa, Buyan & Mullins
Application Number: 0/103,457
Classifications
Current U.S. Class:
D/3264;
D3/263
International Classification: 0301;
International Classification: 0301;